These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26501748)

  • 1. Chemotherapy for Malignant Intraocular Tumors.
    Shah CP; Shields CL; Shields JA
    Dev Ophthalmol; 2016; 55():337-43. PubMed ID: 26501748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy.
    Shields CL; Fulco EM; Arias JD; Alarcon C; Pellegrini M; Rishi P; Kaliki S; Bianciotto CG; Shields JA
    Eye (Lond); 2013 Feb; 27(2):253-64. PubMed ID: 22995941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoblastoma: evidence for stage-based chemotherapy.
    Chung CY; Medina CA; Aziz HA; Singh AD
    Int Ophthalmol Clin; 2015; 55(1):63-75. PubMed ID: 25436494
    [No Abstract]   [Full Text] [Related]  

  • 4. Alternative Chemotherapeutic Agents for the Treatment of Retinoblastoma Using the Intra-Arterial and Intravitreal Routes: A Path Forward Toward Drug Discovery.
    Yuan S; Friedman DL; Daniels AB
    Int Ophthalmol Clin; 2017; 57(1):129-141. PubMed ID: 27898619
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy.
    Shields CL; Lally SE; Leahey AM; Jabbour PM; Caywood EH; Schwendeman R; Shields JA
    Curr Opin Ophthalmol; 2014 Sep; 25(5):374-85. PubMed ID: 25014750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
    Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL
    Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.
    Shields CL; Shields JA
    Curr Opin Ophthalmol; 2010 May; 21(3):203-12. PubMed ID: 20224400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of Chemotherapy Approaches for the Treatment of Intraocular Retinoblastoma: A Comprehensive Review.
    Yuan S; Friedman DL; Daniels AB
    Int Ophthalmol Clin; 2017; 57(1):117-128. PubMed ID: 27898618
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds.
    Smith SJ; Pulido JS; Salomão DR; Smith BD; Mohney B
    Br J Ophthalmol; 2012 Aug; 96(8):1073-7. PubMed ID: 22368261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoblastoma: achieving new standards with methods of chemotherapy.
    Kaliki S; Shields CL
    Indian J Ophthalmol; 2015 Feb; 63(2):103-9. PubMed ID: 25827539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.
    Gobin YP; Dunkel IJ; Marr BP; Brodie SE; Abramson DH
    Arch Ophthalmol; 2011 Jun; 129(6):732-7. PubMed ID: 21320950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin sealant for retinoblastoma: where are we?
    Martin NE; Kim JW; Abramson DH
    J Ocul Pharmacol Ther; 2008 Oct; 24(5):433-8. PubMed ID: 18788992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoblastoma: direct chemotherapeutic drug delivery into the vitreous cavity.
    Seregard S; Singh AD
    Br J Ophthalmol; 2012 Apr; 96(4):473-4. PubMed ID: 22421997
    [No Abstract]   [Full Text] [Related]  

  • 14. What do we know about intraocular carboplatin?
    Kang KB; Francis JH; Abramson DH
    J Ocul Pharmacol Ther; 2014 Nov; 30(9):688-90. PubMed ID: 25188831
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemosurgery for retinoblastoma: what we know after 5 years.
    Abramson DH
    Arch Ophthalmol; 2011 Nov; 129(11):1492-4. PubMed ID: 22084221
    [No Abstract]   [Full Text] [Related]  

  • 16. Intra-arterial chemotherapy in retinoblastoma - A paradigm change.
    Manjandavida FP; Stathopoulos C; Zhang J; Honavar SG; Shields CL
    Indian J Ophthalmol; 2019 Jun; 67(6):740-754. PubMed ID: 31124482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What's New in Intra-Arterial Chemotherapy for Retinoblastoma?
    Abramson DH; Francis JH; Gobin YP
    Int Ophthalmol Clin; 2019; 59(2):87-94. PubMed ID: 30908282
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse Events, Treatment Burden, and Outcomes of Intravenous versus Intra-arterial Chemotherapy for Retinoblastoma.
    Santapuram PR; Schremp EA; Friedman DL; Koyama T; Froehler MT; Daniels AB
    Ophthalmol Retina; 2021 Mar; 5(3):309-312. PubMed ID: 32920208
    [No Abstract]   [Full Text] [Related]  

  • 19. Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey.
    Shields CL; Shields JA
    Clin Exp Ophthalmol; 2010 Aug; 38(6):638-43. PubMed ID: 20584015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electrophysiological evaluation of retinal function after systemic and superselective intra-arterial chemotherapy for retinoblastoma].
    Zueva MV; Saakyan SV; Zueva MV; Saakyan SV
    Vestn Oftalmol; 2015; 131(5):111-114. PubMed ID: 26845881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.